Literature DB >> 10445026

Two-step synergism between the progesterone receptor and the DNA-binding domain of nuclear factor 1 on MMTV minichromosomes.

L Di Croce1, R Koop, P Venditti, H M Westphal, K P Nightingale, D F Corona, P B Becker, M Beato.   

Abstract

In contrast to its behavior as naked DNA, the MMTV promoter assembled in minichromosomes can be activated synergistically by the progesterone receptor and NF1 in a process involving ATP-dependent chromatin remodeling. The DNA-binding domain of NF1 is required and sufficient for stable occupancy of all receptor-binding sites and for functional synergism. Activation of purified minichromosomes is observed in the absence of SWI/SNF and can be enhanced by recombinant ISWI. Receptor binding to minichromosomes recruits ISWI and NURF38, but not brahma. We propose a two-step synergism in which the receptor triggers a chromatin remodeling event that facilitates access of NF1, which in turn stabilizes an open nucleosomal conformation required for efficient binding of further receptor molecules and full transactivation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10445026     DOI: 10.1016/s1097-2765(00)80186-0

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  38 in total

1.  Recruitment of the SWI-SNF chromatin remodeling complex as a mechanism of gene activation by the glucocorticoid receptor tau1 activation domain.

Authors:  A E Wallberg; K E Neely; A H Hassan; J A Gustafsson; J L Workman; A P Wright
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

2.  Chromatin fine structure profiles for a developmentally regulated gene: reorganization of the lysozyme locus before trans-activator binding and gene expression.

Authors:  J Kontaraki; H H Chen; A Riggs; C Bonifer
Journal:  Genes Dev       Date:  2000-08-15       Impact factor: 11.361

3.  Structure and dynamic properties of a glucocorticoid receptor-induced chromatin transition.

Authors:  T M Fletcher; B W Ryu; C T Baumann; B S Warren; G Fragoso; S John; G L Hager
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

4.  Targeting of SWI/SNF chromatin remodelling complexes to estrogen-responsive genes.

Authors:  Borja Belandia; Rob L Orford; Helen C Hurst; Malcolm G Parker
Journal:  EMBO J       Date:  2002-08-01       Impact factor: 11.598

5.  Hormone-induced repression of genes requires BRG1-mediated H1.2 deposition at target promoters.

Authors:  Ana Silvina Nacht; Andy Pohl; Roser Zaurin; Daniel Soronellas; Javier Quilez; Priyanka Sharma; Roni H Wright; Miguel Beato; Guillermo P Vicent
Journal:  EMBO J       Date:  2016-07-07       Impact factor: 11.598

Review 6.  Minireview: role of kinases and chromatin remodeling in progesterone signaling to chromatin.

Authors:  Guillermo P Vicent; A Silvina Nacht; Roser Zaurín; Cecilia Ballaré; Jaime Clausell; Miguel Beato
Journal:  Mol Endocrinol       Date:  2010-05-19

7.  Regulation of V(D)J recombination by nucleosome positioning at recombination signal sequences.

Authors:  Matthias Baumann; Adamantios Mamais; Fraser McBlane; Hua Xiao; Joan Boyes
Journal:  EMBO J       Date:  2003-10-01       Impact factor: 11.598

8.  Nuclear factor 1 synergizes with progesterone receptor on the mouse mammary tumor virus promoter wrapped around a histone H3/H4 tetramer by facilitating access to the central hormone-responsive elements.

Authors:  Guillermo Pablo Vicent; Roser Zaurin; A Silvina Nacht; Jofre Font-Mateu; Francois Le Dily; Miguel Beato
Journal:  J Biol Chem       Date:  2009-11-24       Impact factor: 5.157

Review 9.  Erk signaling and chromatin remodeling in MMTV promoter activation by progestins.

Authors:  Guillermo P Vicent; Roser Zaurin; Cecilia Ballaré; A Silvina Nacht; Miguel Beato
Journal:  Nucl Recept Signal       Date:  2009-10-02

10.  Two chromatin remodeling activities cooperate during activation of hormone responsive promoters.

Authors:  Guillermo Pablo Vicent; Roser Zaurin; A Silvina Nacht; Ang Li; Jofre Font-Mateu; Francois Le Dily; Michiel Vermeulen; Matthias Mann; Miguel Beato
Journal:  PLoS Genet       Date:  2009-07-17       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.